Threshold Pharmaceuticals

About:

Threshold Pharmaceuticals is focused on the development of drugs targeting Tumor Hypoxia, a low oxygen condition found in solid tumors.

Website: http://www.thresholdpharm.com

Top Investors: Sutter Hill Ventures, Sofinnova Investments, Merck, Great Point Partners, Cancer Prevention and Research Institute of Texas

Description:

Threshold is a biotechnology company focused on the discovery and development of drugs targeting Tumor Hypoxia, the low oxygen condition found in microenvironments of most solid tumors. This approach offers broad potential to treat most solid tumors. By selectively targeting tumor cells, they are building a pipeline of drugs that hold promise to be more effective and less toxic to healthy tissues than conventional anticancer drugs.

Total Funding Amount:

$138M

Estimated Revenue Range:

Less than $1M

Headquarters Location:

South San Francisco, California, United States

Founded Date:

2001-01-01

Contact Email:

ir(AT)thresholdpharm.com

Founders:

George F. Tidmarsh

Number of Employees:

11-50

Last Funding Date:

2017-03-17

IPO Status:

Delisted

Industries:

© 2025 bioDAO.ai